Paper36085537
Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.
Volta M. Neurotherapeutics, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models. Papers, record 36085537. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36085537
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| alpha-Synuclein | Major topic |
| Glucosylceramidase | Major topic |
| Lysosomes | Major topic |
| Parkinson Disease | Major topic |
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Major topic |
| Animals | |
| Mutation |
Source PubMed
References130
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34550621 | Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity. | Mov Disord | 2022 | https://conductscience.org/library/papers/34550621 | PubMed |
| 2 | 6823561 | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. | Science | 1983 | https://conductscience.org/library/papers/6823561 | PubMed |
| 3 | 15333840 | Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. | Science | 2004 | https://conductscience.org/library/papers/15333840 | PubMed |
| 4 | 27859541 | Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice. | Ann Neurol | 2016 | https://conductscience.org/library/papers/27859541 | PubMed |
| 5 | 17362839 | Autophagy and neurodegeneration: when the cleaning crew goes on strike. | Lancet Neurol | 2007 | https://conductscience.org/library/papers/17362839 | PubMed |
| 6 | 9197268 | Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. | Science | 1997 | https://conductscience.org/library/papers/9197268 | PubMed |
| 7 | 31039583 | LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/31039583 | PubMed |
| 8 | 21494637 | Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. | PLoS One | 2011 | https://conductscience.org/library/papers/21494637 | PubMed |
| 9 | 34340748 | Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice. | Elife | 2021 | https://conductscience.org/library/papers/34340748 | PubMed |
| 10 | 34419621 | Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. | Neurobiol Dis | 2021 | https://conductscience.org/library/papers/34419621 | PubMed |
| 11 | 12941575 | The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? | Lancet Neurol | 2003 | https://conductscience.org/library/papers/12941575 | PubMed |
| 12 | 17101029 | Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. | J Neurochem | 2007 | https://conductscience.org/library/papers/17101029 | PubMed |
| 13 | 31920513 | Autophagy and LRRK2 in the Aging Brain. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31920513 | PubMed |
| 14 | 29704272 | Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic. | Mov Disord | 2018 | https://conductscience.org/library/papers/29704272 | PubMed |
| 15 | 24244710 | Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs. | PLoS One | 2013 | https://conductscience.org/library/papers/24244710 | PubMed |
| 16 | 19878656 | Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19878656 | PubMed |
| 17 | 27413152 | G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons. | J Neurosci | 2016 | https://conductscience.org/library/papers/27413152 | PubMed |
| 18 | 29703245 | D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model. | Acta Neuropathol Commun | 2018 | https://conductscience.org/library/papers/29703245 | PubMed |
| 19 | 32034799 | Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition. | Mov Disord | 2020 | https://conductscience.org/library/papers/32034799 | PubMed |
| 20 | 17512502 | Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. | Brain Res | 2007 | https://conductscience.org/library/papers/17512502 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42707090 | Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42707090 | PubMed |
| 41467444 | Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson's disease. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41467444 | PubMed |
| 41383374 | Mass spectrometry-based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease. | Neuroprotection | 2024 | https://conductscience.org/library/papers/41383374 | PubMed |
| 41257354 | Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa. | Mov Disord | 2026 | https://conductscience.org/library/papers/41257354 | PubMed |
| 40629324 | Recent advances in targeting LRRK2 for Parkinson's disease treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40629324 | PubMed |
| 39760821 | Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease. | Neurol Sci | 2025 | https://conductscience.org/library/papers/39760821 | PubMed |
| 37017897 | A New Look at Animal Models of Neurological Disorders. | Neurotherapeutics | 2023 | https://conductscience.org/library/papers/37017897 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GBA1 | 2629 | PubTator's text mining | https://conductscience.org/library/genes/2629 | NCBI Gene |
| LRRK2 | 120892 | PubTator's text mining | https://conductscience.org/library/genes/120892 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
| TPCN2 | 219931 | PubTator's text mining | https://conductscience.org/library/genes/219931 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36085537
GET https://conductscience.org/api/papers/v1/36085537/references?page=2